Key result
CIC-rearranged sarcomas show a 25% overall survival rate at two years.
Why the study?
CIC-rearranged sarcomas represent a distinct rare pathological entity within the spectrum of undifferentiated small round cell sarcomas.
Answers are grounded in this paper and cite their sources.
The study expands the clinicopathological spectrum of CIC-rearranged sarcomas by identifying novel visceral locations and supports the use of DNA methylation profiling for accurate diagnosis.
CIC-rearranged sarcomas represent a distinct rare pathological entity within the spectrum of undifferentiated small round cell sarcomas. This single institution retrospective study investigates the histopathological, molecular, and clinical characteristics of a cohort of 14 CIC-rearranged sarcomas. These tumors were diagnosed in eight male and six female patients, with the age at initial diagnosis ranging from 8 to 67 years and a mean age of 23.7 years. Among the patients, three novel locations of CIC::DUX4 sarcomas were detected in the mesentery, pancreas, and pterygopalatine fossa. Genetically, we identified 12 cases as CIC::DUX4 sarcomas and two as sarcomas with CIC gene rearrangement detected by break-apart fluorescence in situ hybridization only. The most common gene translocation had a breakpoint located in exon 20 of the CIC gene and exon 1 of the DUX4 gene; this alteration was found in 83% of all CIC::DUX4 cases we identified. We also performed DNA methylation analysis on seven cases, which was proven to be a reliable method with high sensitivity for clustering CIC-rearranged sarcomas.
No takes yet. Share an insight, caveat, or question.
Balko et al. (2026) studied Patients with CIC-rearranged sarcomas diagnosed at a single institution, including children and adults aged 8 to 67 years, involving soft tissues and visceral organs (n=14). CIC-rearranged sarcomas had a 2-year overall survival rate of 25% in a cohort of 14 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: